Theravance Biopharma Inc (TBPH)
R&D Expense Growth
-19.16%
Quarterly · Period ending:
TBPH R&D Expense Growth
Latest reported-19.16%period ending
Latest reported-19.16%period ending
TBPH Quarterly R&D Growth (QoQ) (0.00% → -19.16%)
Latest values, visible window
High-resolution chart · PNG
TBPH r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -19.1628% | |
| -16.2861% | |
| -14.1642% | |
| -22.6692% | |
| -8.4003% | |
| 22.1547% | |
| 1.1545% | |
| -6.8917% | |
| 10.9946% | |
| -0.3002% | |
| 14.1642% | |
| -30.7158% | |
| -30.34% | |
| -5.6031% | |
| 50.0694% | |
| -30.0176% | |
| -33.5713% | |
| -25.1766% | |
| -29.5706% | |
| -10.1484% | |
| -24.1536% | |
| -0.6077% | |
| 3.0814% | |
| 7.9594% | |
| -5.4671% | |
| -1.5099% | |
| 28.8794% | |
| 12.0843% | |
| -13.7854% | |
| 2.9635% | |
| -0.8047% | |
| 8.375% | |
| 1.7921% | |
| -6.4367% | |
| 29.7588% | |
| -8.3491% | |
| 5.8228% | |
| -3.4466% | |
| 31.492% | |
| -0.368% | |
| -10.1155% | |
| 10.1105% | |
| 6.7014% | |
| -0.0329% | |
| -15.664% | |
| -14.6307% | |
| 10.0929% | |
| -17.1964% | |
| 10.9292% | |
| 28.4971% | |
| 0.5232% | |
| 6.2533% | |
| 19.6474% | |
| -9.6958% | |
| 7.8462% | |
| 0% |